Clinical Experience with First-generation Epidermal Growth Factor Receptor 
Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients 
with Brain Metastasis

Clinical Experience with First-generation Epidermal Growth Factor Receptor 
Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients 
with Brain Metastasis

Background and objective A survival analysis and the influencing factors for non-small cell lung cancer (NSCLC) patients with brain metastases accepting first-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKIs) treatment have not yet been elucidated to date. In this stu...

Full description

Bibliographic Details
Main Authors: Huixing DONG, Shaohua CUI, Feng PAN, Lili DONG, Yanjie NIU, Yizhuo ZHAO, Aiqin GU, Xiaoyan JIN, Liyan JIANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2017-02-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Brain metastases
Epidermal growth factor receptor-tyrosine kinase inhibitors
Survival
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2017.02.06

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2017.02.06

Similar Items